Cellular Origins, a TTP company focused on optimising the manufacturing of cell and gene therapies, today announced the appointment of Peter Crossley as Chief Operating Officer (COO).
With 27 years’ experience in novel technology and product development, Peter will bolster Cellular Origins’ mission to develop scalable automation solutions for cell therapy manufacture that will improve patient access to these potentially life-saving treatments.
In the new role, Peter will lead the ongoing development and delivery of Cellular Origins’ products by driving team growth and overseeing people development.
Peter has been instrumental in the delivery of ground-breaking life science products sold worldwide and the invention and delivery of highly complex, novel manufacturing systems.
He has worked as a Consultant at TTP for the past 17 years, in this time playing a key role in growing TTP’s life science business.
He was most recently interim CTO at Depixus.
With a BEng in Aerospace Engineering from the University of Bristol, Peter began his career in gas turbine development at Rolls-Royce, before moving to R&D and technical management in consumer products at Dyson and Fisher & Paykel.
Peter Crossley, COO at Cellular Origins, said: “Cellular Origins is in an exciting phase of growth. As COO, I look forward to driving the expansion of Cellular Origins’ world-class team, as well as supporting them to bring about a revolution in cell therapy manufacture that will deliver these life changing treatments to all who need them.”
